An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504916-14-00

Acronym

AZA-001-31-02

Enrollment

Registered

2023-06-21

Start date

2023-07-13

Completion date

2023-08-25

Last updated

2023-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycosphingolipid lysosomal storage disorders

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026